Targeted delivery of cytotoxic NAMPT inhibitors using antibody-drug conjugates

被引：0
|
作者：
Neumann, Christopher S. [1 ]
Olivas, Kathleen C. [1 ]
Waight, Andrew B. [1 ]
Meyer, David [1 ]
Loftus, Luke V. [1 ]
Zaval, Margo [1 ]
Anderson, Martha E. [1 ]
Jin, Steven [1 ]
Cochran, Julia H. [1 ]
Simmons, Jessica K. [1 ]
Pittman, Paul G. [1 ]
Lyon, Robert P. [1 ]
Senter, Peter D. [1 ]
机构：
[1] Seattle Genet, Bothell, WA USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-930
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
930
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Natural products as a source of cytotoxic warheads in antibody-drug conjugates
    Goel, Bharat
    Jain, Shreyans K.
    NATURAL PRODUCT RESEARCH, 2023, 37 (17) : 2973 - 2985
  • [22] Antibody-Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal Antibodies
    Ducry, Laurent
    Stump, Bernhard
    BIOCONJUGATE CHEMISTRY, 2010, 21 (01) : 5 - 13
  • [23] Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody-drug conjugates
    Staben, Leanna R.
    Koenig, Stefan G.
    Lehar, SophieM.
    Vandlen, Richard
    Zhang, Donglu
    Chuh, Josefa
    Yu, Shang-Fan
    Ng, Carl
    Guo, Jun
    Liu, Yanzhou
    Fourie-O'Donohue, Aimee
    Go, MaryAnn
    Xin Linghu
    Segraves, Nathaniel L.
    Wang, Tao
    Chen, Jinhua
    Wei, BinQing
    Phillips, Gail D. Lewis
    Xu, Keyang
    Kozak, Katherine R.
    Mariathasan, Sanjeev
    Flygare, John A.
    Pillow, Thomas H.
    NATURE CHEMISTRY, 2016, 8 (12) : 1112 - 1119
  • [24] Antibody–drug conjugates for targeted anticancer drug delivery
    Kim Y.
    Park E.J.
    Na D.H.
    Journal of Pharmaceutical Investigation, 2016, 46 (4) : 341 - 349
  • [25] Antibody-drug conjugates targeted at human aspartyl (asparaginyl) β-hydroxylase
    Malhotra, Kanam
    Walker, Susan
    Fang, Chen
    Birthare, Karamveer
    Lebowitz, Michael S.
    Fuller, Steven
    Sesay, Muctarr
    Ghanbari, Hossein A.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [26] In vivo behaviour of antibody-drug conjugates for the targeted treatment of cancer
    Xie, HS
    Blättler, WA
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (03) : 281 - 291
  • [27] Antibody-drug conjugates: the paradigm shifts in the targeted cancer therapy
    Aggarwal, Devesh
    Yang, Jie
    Salam, Md. Abdus
    Sengupta, Sagnik
    Al-Amin, Md. Yusuf
    Mustafa, Saad
    Khan, Mohammad Aasif
    Huang, Xun
    Pawar, Jogendra Singh
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [28] Natural Products as Exquisitely Potent Cytotoxic Payloads for Antibody-Drug Conjugates
    Gromek, Samantha M.
    Balunas, Marcy J.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (24) : 2822 - 2834
  • [29] Improving the Therapeutic Index in Cancer Therapy by Using Antibody-Drug Conjugates Designed with a Moderately Cytotoxic Drug
    Govindan, Serengulam V.
    Cardillo, Thomas M.
    Rossi, Edmund A.
    Trisal, Preeti
    McBride, William J.
    Sharkey, Robert M.
    Goldenberg, David M.
    MOLECULAR PHARMACEUTICS, 2015, 12 (06) : 1836 - 1847
  • [30] Enthusiasm for Antibody-Drug Conjugates
    Tuma, Rabiya S.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (20) : 1493 - 1494
12345